ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	108.31	78.34	-18.52	18.78	-47.9	-42.6
Depreciation & Amortization	85.8	91.42	67.73	59.79	59.65	47.25
Loss (Gain) From Sale of Assets	0.38	0.38	-5.35	-	-0.75	-1.82
Asset Writedown & Restructuring Costs	0.77	0.77	7.6	-	1.73	2.37
Loss (Gain) From Sale of Investments	-9.91	-2.82	-6.31	-	-	-
Stock-Based Compensation	41.06	37.93	29.34	20.65	14.6	10.49
Other Operating Activities	0.96	-13.66	0.7	-5.12	-7.23	-12.28
Change in Accounts Receivable	-48.37	-58.53	-21.09	3.36	-36.91	-5.55
Change in Inventory	-4.56	-5.96	-21.29	-5.84	-23.63	3.22
Change in Accounts Payable	10.77	15.16	0.48	7.55	5.04	10.17
Change in Income Taxes	0.24	-15.53	-1.42	11.99	-0.16	-7.57
Change in Other Net Operating Assets	4.01	57.74	32.13	7.8	4.36	-0.35
Operating Cash Flow	189.47	185.23	64.02	118.96	-31.2	3.32
Operating Cash Flow Growth	36.17%	189.34%	-46.19%	-	-	-78.24%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-16.48	-13.84	-16.24	-8.87	-8.88	-2.56
Sale of Property, Plant & Equipment	-	-	13.51	-	0.75	2.65
Cash Acquisitions	-	-	-401.28	-	-0.03	-84.49
Sale (Purchase) of Intangibles	-5.47	-20.49	-0.72	-9.64	-7.58	-21.08
Investing Cash Flow	-21.94	-34.32	-404.72	-18.51	-15.74	-105.48

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	641.25	-	-	310.03
Long-Term Debt Repaid	-	-10.16	-296.03	-3	-3	-211.01
Total Debt Repaid	-14.22	-10.16	-296.03	-3	-3	-211.01
Net Debt Issued (Repaid)	-14.22	-10.16	345.22	-3	-3	99.02
Issuance of Common Stock	12.34	13.6	6.49	89.55	1.46	71.65
Repurchase of Common Stock	-22.22	-12.21	-10.96	-4.99	-1.96	-0.89
Preferred Dividends Paid	-0.34	-1.16	-1.63	-1.63	-1.63	-0.19
Dividends Paid	-0.34	-1.16	-1.63	-1.63	-1.63	-0.19
Other Financing Activities	-0.11	-0.03	-74.18	-12.5	-	-
Financing Cash Flow	-24.55	-9.94	264.95	67.44	-5.13	194.6

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.55	-0.23	-0.47	-	-	-
Net Cash Flow	142.41	140.73	-76.23	167.89	-52.07	92.43

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	172.99	171.39	47.78	110.09	-40.08	0.77
Free Cash Flow Growth	37.90%	258.70%	-56.60%	-	-	-91.62%
Free Cash Flow Margin	17.68%	19.40%	7.78%	22.61%	-12.67%	0.35%
Free Cash Flow Per Share	7.85	8.07	2.47	6.05	-2.46	0.06
Levered Free Cash Flow	132.21	119.42	42.67	114.36	-38.7	-28.62
Unlevered Free Cash Flow	151.52	139.53	63.38	136.26	-20.94	-21.16

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	25.31	26.93	24.38	31.43	21.48	9.71
Cash Income Tax Paid	14.14	17.67	19.06	1.23	0.29	10.37
Change in Working Capital	-37.91	-7.12	-11.19	24.86	-51.3	-0.08

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error